BAUSCH + LOMB CORPORATION COMMON SHARES (BLCO)
Bausch + Lomb Announces Second R&D “Teach-in” Webinar
Bausch + Lomb Announces Second R&D “Teach-in” Webinar
X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
TIC Solutions to Host and Webcast 2026 Investor Day on May 19, 2026
Change in holdings of interested parties/officers - Moshe Magid
Anavex Board Appoints Former SVP of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer
CDW Declares Quarterly Cash Dividend of $0.630 Per Share
Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
Metropolitan Bank Holding Corp. Named to 2026 KBW Bank Honor Roll
Cyngn Announces Date for First Quarter 2026 Financial Results
Royalty Pharma reports first quarter 2026 results